DR. HUNG DINH NGUYEN MD
Prescription History 1740395607
Internal Medicine in Saratoga Springs, NY

Active since August 20, 2006PECOS EnrolledAccepts Medicare Assignment
65.44/100
CMS Quality Rating
19 WEST AVE STE 201, SARATOGA HOSPITAL PULMONOLOGY AND SLEEP MEDICINE, SARATOGA SPRINGS, NY 12866(518) 693-4635 Get Directions

NPPES record last updated: February 24, 2017. Verified against the NPPES registry weekly; last sync: August 16, 2026.

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. HUNG DINH NGUYEN MD, an active Internal Medicine specialist practicing in Saratoga Springs, NY. Our medical registry currently tracks 38 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 4,517 documented patient claims. Among these therapy options, the most frequently utilized medication is Trelegy Ellipta, which accounts for 826 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

38
Medications
4,517
Total Claims
6,920
30-Day Fills
Trelegy Ellipta
Most Prescribed · 826 claims
View details
38 medications · 2023 Medicare Part D
Medicare Part D medications prescribed by DR. HUNG DINH NGUYEN MD in 2023, with prescription volumes, average cost per fill, and NY state comparisons
Medication Prescriptions (2023)Rx (2023) Avg Cost per FillCost / Fill Vs. Other NY PrescribersVs. NY Avg

About Trelegy Ellipta: This product is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma and ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾

Controlling symptoms of breathing problems helps you stay active. This inhaler contains 3 medications: fluticasone, umeclidinium, and vilanterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing swelling of the airways in the lungs to make breathing easier. Umeclidinium belongs to a class of drugs known as anticholinergics and vilanterol is a LABA medication. Both drugs work by relaxing the muscles around the airways so that they open up and you can breathe more easily. Both drugs are also known as bronchodilators. When used alone, long-acting beta agonists (such as vilanterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination products containing both an inhaled corticosteroid and long-acting beta agonist, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with two asthma-control medications (such as inhaled corticosteroid and long-acting beta agonist) or if your symptoms need combination treatment. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath. If sudden breathing problems occur, use your quick-relief inhaler as prescribed.

In 2023, this provider wrote 826 Medicare prescriptions for Trelegy Ellipta, about 15 times the volume of the typical New York prescriber of this medication (55). Medicare paid an average of $930.05 per fill, versus $849.96 statewide.

How often this provider prescribes it

This provider
826
NY average
55.0

This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$930.05
NY average
$849.96

Gross Part D cost per fill; not the patient's out-of-pocket price.

1,173
30-Day Fills
standardized to 30-day supplies
35,190
Days of Medication
total across all patients in 2023

About Albuterol Sulfate Hfa: Albuterol (also known as salbutamol) is used to treat wheezing and shortness of breath caused by breathing problems such as asthma. Show more ▾

It is a quick-relief medication. Albuterol belongs to a class of drugs known as bronchodilators. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.

In 2023, this provider wrote 516 Medicare prescriptions for Albuterol Sulfate Hfa, about 7.8 times the volume of the typical New York prescriber of this medication (66). Medicare paid an average of $49.52 per fill, versus $47.16 statewide.

How often this provider prescribes it

This provider
516
NY average
66.0

This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$49.52
NY average
$47.16

Gross Part D cost per fill; not the patient's out-of-pocket price.

691.6
30-Day Fills
standardized to 30-day supplies
17,029
Days of Medication
total across all patients in 2023

About Prednisone: Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Show more ▾

Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.

In 2023, this provider wrote 391 Medicare prescriptions for Prednisone, about 8.9 times the volume of the typical New York prescriber of this medication (44). Medicare paid an average of $6.42 per fill, versus $6.20 statewide.

How often this provider prescribes it

This provider
391
NY average
44.0

This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$6.42
NY average
$6.20

Gross Part D cost per fill; not the patient's out-of-pocket price.

435.8
30-Day Fills
standardized to 30-day supplies
7,906
Days of Medication
total across all patients in 2023

About Azithromycin: This medication is used to treat certain eye infections. Show more ▾

It is a macrolide antibiotic that works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. A semi-synthetic macrolide antibiotic structurally related to ERYTHROMYCIN. It has been used in the treatment of Mycobacterium avium intracellulare infections, toxoplasmosis, and cryptosporidiosis.

In 2023, this provider wrote 372 Medicare prescriptions for Azithromycin, about 9.8 times the volume of the typical New York prescriber of this medication (38). Medicare paid an average of $19.43 per fill, versus $8.47 statewide.

How often this provider prescribes it

This provider
372
NY average
38.0

This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$19.43
NY average
$8.47

Gross Part D cost per fill; not the patient's out-of-pocket price.

498.2
30-Day Fills
standardized to 30-day supplies
11,873
Days of Medication
total across all patients in 2023

About Breo Ellipta: This medication is used to prevent and decrease symptoms (wheezing and trouble breathing) caused by asthma and ongoing lung disease (chronic obstructive pulmonary disease-COPD, including chronic bronchitis and emphysema). Show more ▾

This inhaler contains 2 medications: fluticasone and vilanterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing the swelling of the airways in the lungs to make breathing easier. Vilanterol belongs to a class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. When used alone, long-acting beta agonists (like vilanterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with one asthma-control medication (such as inhaled corticosteroid) or if your symptoms need combination treatment. Before using this medication, it is important to learn how to use it properly. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed.

In 2023, this provider wrote 297 Medicare prescriptions for Breo Ellipta, about 8 times the volume of the typical New York prescriber of this medication (37). Medicare paid an average of $606.48 per fill, versus $531.93 statewide.

How often this provider prescribes it

This provider
297
NY average
37.0

This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$606.48
NY average
$531.93

Gross Part D cost per fill; not the patient's out-of-pocket price.

448
30-Day Fills
standardized to 30-day supplies
13,440
Days of Medication
total across all patients in 2023

About Montelukast Sodium: Montelukast is used to control and prevent symptoms caused by asthma (such as wheezing and shortness of breath). Show more ▾

It is also used before exercise to prevent breathing problems during exercise (bronchospasm). This medication can help decrease the number of times you need to use your quick relief inhaler. Montelukast is also used to relieve symptoms of hay fever and allergic rhinitis (such as sneezing, stuffy/runny/itchy nose). Since there are other allergy medications that may be safer (see also Warning section), this medication should be used for this condition only when you cannot take other allergy medications or they do not work well. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks or breathing problems. If an asthma attack or sudden shortness of breath occurs, use your quick-relief inhaler as prescribed. This drug works by blocking certain natural substances (leukotrienes) that may cause or worsen asthma and allergies. It helps make breathing easier by reducing swelling (inflammation) in the airways.

In 2023, this provider wrote 267 Medicare prescriptions for Montelukast Sodium, about 4.9 times the volume of the typical New York prescriber of this medication (55). Medicare paid an average of $14.43 per fill, versus $15.11 statewide.

How often this provider prescribes it

This provider
267
NY average
55.0

This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$14.43
NY average
$15.11

This provider's average cost per fill is below the NY average for this medication.

743.3
30-Day Fills
standardized to 30-day supplies
22,299
Days of Medication
total across all patients in 2023

About Spiriva Respimat: Tiotropium is used to control and prevent symptoms (such as wheezing, shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD which includes bronchitis and emphysema). Show more ▾

It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Tiotropium belongs to a class of drugs known as anticholinergics. Controlling symptoms of breathing problems can decrease time lost from work or school. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden breathing problems. If wheezing or sudden shortness of breath occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. A scopolamine derivative and CHOLINERGIC ANTAGONIST that functions as a BRONCHODILATOR AGENT. It is used in the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE.

In 2023, this provider wrote 266 Medicare prescriptions for Spiriva Respimat, about 8.6 times the volume of the typical New York prescriber of this medication (31). Medicare paid an average of $999.88 per fill, versus $695.14 statewide.

How often this provider prescribes it

This provider
266
NY average
31.0

This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$999.88
NY average
$695.14

Gross Part D cost per fill; not the patient's out-of-pocket price.

503.4
30-Day Fills
standardized to 30-day supplies
15,057
Days of Medication
total across all patients in 2023

About Incruse Ellipta: Umeclidinium is used to control and prevent symptoms (such as wheezing, shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes bronchitis and emphysema). Show more ▾

It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Umeclidinium belongs to a class of drugs known as anticholinergics. Controlling symptoms of breathing problems can decrease time lost from work or school. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath. If wheezing or sudden shortness of breath occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed.

In 2023, this provider wrote 248 Medicare prescriptions for Incruse Ellipta, about 8 times the volume of the typical New York prescriber of this medication (31). Medicare paid an average of $539.77 per fill, versus $468.20 statewide.

How often this provider prescribes it

This provider
248
NY average
31.0

This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$539.77
NY average
$468.20

Gross Part D cost per fill; not the patient's out-of-pocket price.

370
30-Day Fills
standardized to 30-day supplies
11,100
Days of Medication
total across all patients in 2023

About Symbicort: This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾

It contains 2 medications: budesonide and formoterol. Budesonide belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Formoterol belongs to the class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. When used alone, long-acting beta agonists (such as formoterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. Before using this medication, it is important to learn how to use it properly. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. See also How to Use section. A pharmaceutical preparation of budesonide and formoterol fumarate that is used as an ANTI-ASTHMATIC AGENT and for the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE.

In 2023, this provider wrote 240 Medicare prescriptions for Symbicort, about 6.7 times the volume of the typical New York prescriber of this medication (36). Medicare paid an average of $802.04 per fill, versus $516.71 statewide.

How often this provider prescribes it

This provider
240
NY average
36.0

This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$802.04
NY average
$516.71

Gross Part D cost per fill; not the patient's out-of-pocket price.

478
30-Day Fills
standardized to 30-day supplies
14,340
Days of Medication
total across all patients in 2023

About Fluticasone-Salmeterol: This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾

It contains 2 medications: fluticasone and salmeterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Salmeterol belongs to the class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. When used alone, long-acting beta agonists (such as salmeterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with one asthma-control medication (such as inhaled corticosteroid) or if your symptoms need combination treatment. Before using this medication, it is important to learn how to use it properly. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed.

In 2023, this provider wrote 114 Medicare prescriptions for Fluticasone-Salmeterol, about 5 times the volume of the typical New York prescriber of this medication (23). Medicare paid an average of $243.45 per fill, versus $245.39 statewide.

How often this provider prescribes it

This provider
114
NY average
23.0

This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$243.45
NY average
$245.39

This provider's average cost per fill is below the NY average for this medication.

164
30-Day Fills
standardized to 30-day supplies
4,905
Days of Medication
total across all patients in 2023

About Wixela Inhub: This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾

It contains 2 medications: fluticasone and salmeterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Salmeterol belongs to the class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. When used alone, long-acting beta agonists (such as salmeterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with one asthma-control medication (such as inhaled corticosteroid) or if your symptoms need combination treatment. Before using this medication, it is important to learn how to use it properly. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed.

In 2023, this provider wrote 112 Medicare prescriptions for Wixela Inhub, about 5.3 times the volume of the typical New York prescriber of this medication (21). Medicare paid an average of $298.92 per fill, versus $285.27 statewide.

How often this provider prescribes it

This provider
112
NY average
21.0

This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$298.92
NY average
$285.27

Gross Part D cost per fill; not the patient's out-of-pocket price.

170
30-Day Fills
standardized to 30-day supplies
5,100
Days of Medication
total across all patients in 2023

About Anoro Ellipta: This product is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾

Controlling symptoms of breathing problems helps you stay active. This inhaler contains 2 medications: umeclidinium and vilanterol. Both drugs work by relaxing the muscles around the airways so that they open up and you can breathe more easily. Umeclidinium belongs to a class of drugs known as anticholinergics. Vilanterol belongs to the class of drugs known as long-acting beta agonists (LABAs). Both drugs are also known as bronchodilators. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath. If sudden breathing problems occur, use your quick-relief inhaler as prescribed. Umeclidinium/vilanterol is not approved to treat asthma. People with asthma using long-acting inhaled beta agonists (such as vilanterol) without also using an inhaled corticosteroid may have an increased risk of serious (sometimes fatal) breathing problems.

In 2023, this provider wrote 104 Medicare prescriptions for Anoro Ellipta, about 3 times the volume of the typical New York prescriber of this medication (35). Medicare paid an average of $647.27 per fill, versus $600.87 statewide.

How often this provider prescribes it

This provider
104
NY average
35.0

This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$647.27
NY average
$600.87

Gross Part D cost per fill; not the patient's out-of-pocket price.

145
30-Day Fills
standardized to 30-day supplies
4,350
Days of Medication
total across all patients in 2023

About Advair Diskus: This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾

It contains 2 medications: fluticasone and salmeterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Salmeterol belongs to the class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. When used alone, long-acting beta agonists (such as salmeterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with one asthma-control medication (such as inhaled corticosteroid) or if your symptoms need combination treatment. Before using this medication, it is important to learn how to use it properly. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed.

In 2023, this provider wrote 69 Medicare prescriptions for Advair Diskus, about 2.7 times the volume of the typical New York prescriber of this medication (26). Medicare paid an average of $649.53 per fill, versus $588.17 statewide.

How often this provider prescribes it

This provider
69
NY average
26.0

This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$649.53
NY average
$588.17

Gross Part D cost per fill; not the patient's out-of-pocket price.

85
30-Day Fills
standardized to 30-day supplies
2,550
Days of Medication
total across all patients in 2023

About Fluticasone Propionate: Fluticasone is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma. Show more ▾

Controlling symptoms of asthma helps you maintain your normal activities and decreases time lost from work or school. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing swelling (inflammation) of the airways in the lungs to make breathing easier. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. A STEROID with GLUCOCORTICOID RECEPTOR activity that is used to manage the symptoms of ASTHMA; ALLERGIC RHINITIS, and ATOPIC DERMATITIS.

In 2023, this provider wrote 61 Medicare prescriptions for Fluticasone Propionate, about the same volume as the typical New York prescriber of this medication (57). Medicare paid an average of $18.25 per fill, versus $15.88 statewide.

How often this provider prescribes it

This provider
61
NY average
57.0

This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$18.25
NY average
$15.88

Gross Part D cost per fill; not the patient's out-of-pocket price.

123.8
30-Day Fills
standardized to 30-day supplies
3,714
Days of Medication
total across all patients in 2023

About Levofloxacin: This medication is used to treat a variety of bacterial infections. Show more ▾

Levofloxacin belongs to a class of drugs known as quinolone antibiotics. It works by stopping the growth of bacteria. Levofloxacin injection is used if you cannot take the medication by mouth. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. The L-isomer of Ofloxacin.

In 2023, this provider wrote 53 Medicare prescriptions for Levofloxacin, about 2 times the volume of the typical New York prescriber of this medication (26). Medicare paid an average of $5.95 per fill, versus $8.82 statewide.

How often this provider prescribes it

This provider
53
NY average
26.0

This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$5.95
NY average
$8.82

This provider's average cost per fill is below the NY average for this medication.

53
30-Day Fills
standardized to 30-day supplies
371
Days of Medication
total across all patients in 2023

About Ipratropium Bromide: Ipratropium is used to control and prevent symptoms (wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD which includes bronchitis and emphysema). Show more ▾

It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. For preventing symptoms of lung disease, this medication must be used regularly to be effective. Use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) for wheezing or sudden shortness of breath unless otherwise directed by your doctor. Ipratropium does not work as fast as your quick-relief inhaler, but may sometimes be used to relieve symptoms of wheezing or sudden shortness of breath if so prescribed by your doctor. A muscarinic antagonist structurally related to ATROPINE but often considered safer and more effective for inhalation use. It is used for various bronchial disorders, in rhinitis, and as an antiarrhythmic.

In 2023, this provider wrote 52 Medicare prescriptions for Ipratropium Bromide, about 1.4 times the volume of the typical New York prescriber of this medication (37). Medicare paid an average of $55.60 per fill, versus $41.95 statewide.

How often this provider prescribes it

This provider
52
NY average
37.0

This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$55.60
NY average
$41.95

Gross Part D cost per fill; not the patient's out-of-pocket price.

88.4
30-Day Fills
standardized to 30-day supplies
2,536
Days of Medication
total across all patients in 2023

About Budesonide-Formoterol Fumarate: This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾

It contains 2 medications: budesonide and formoterol. Budesonide belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Formoterol belongs to the class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. When used alone, long-acting beta agonists (such as formoterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. Before using this medication, it is important to learn how to use it properly. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. See also How to Use section. A pharmaceutical preparation of budesonide and formoterol fumarate that is used as an ANTI-ASTHMATIC AGENT and for the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE.

In 2023, this provider wrote 48 Medicare prescriptions for Budesonide-Formoterol Fumarate, about 2.7 times the volume of the typical New York prescriber of this medication (18). Medicare paid an average of $466.77 per fill, versus $361.98 statewide.

How often this provider prescribes it

This provider
48
NY average
18.0

This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$466.77
NY average
$361.98

Gross Part D cost per fill; not the patient's out-of-pocket price.

96
30-Day Fills
standardized to 30-day supplies
2,880
Days of Medication
total across all patients in 2023

About Fluticasone-Vilanterol: This medication is used to prevent and decrease symptoms (wheezing and trouble breathing) caused by asthma and ongoing lung disease (chronic obstructive pulmonary disease-COPD, including chronic bronchitis and emphysema). Show more ▾

This inhaler contains 2 medications: fluticasone and vilanterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing the swelling of the airways in the lungs to make breathing easier. Vilanterol belongs to a class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. When used alone, long-acting beta agonists (like vilanterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with one asthma-control medication (such as inhaled corticosteroid) or if your symptoms need combination treatment. Before using this medication, it is important to learn how to use it properly. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed.

In 2023, this provider wrote 46 Medicare prescriptions for Fluticasone-Vilanterol, about 2.9 times the volume of the typical New York prescriber of this medication (16). Medicare paid an average of $391.45 per fill, versus $450.29 statewide.

How often this provider prescribes it

This provider
46
NY average
16.0

This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$391.45
NY average
$450.29

This provider's average cost per fill is below the NY average for this medication.

62
30-Day Fills
standardized to 30-day supplies
1,860
Days of Medication
total across all patients in 2023

About Spiriva Handihaler: Tiotropium is used to control and prevent symptoms (such as wheezing, shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD which includes bronchitis and emphysema). Show more ▾

It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Tiotropium belongs to a class of drugs known as anticholinergics. Controlling symptoms of breathing problems can decrease time lost from work or school. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden breathing problems. If wheezing or sudden shortness of breath occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. A scopolamine derivative and CHOLINERGIC ANTAGONIST that functions as a BRONCHODILATOR AGENT. It is used in the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE.

In 2023, this provider wrote 46 Medicare prescriptions for Spiriva Handihaler, about 2.1 times the volume of the typical New York prescriber of this medication (22). Medicare paid an average of $1,033.34 per fill, versus $759.00 statewide.

How often this provider prescribes it

This provider
46
NY average
22.0

This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$1,033.34
NY average
$759.00

Gross Part D cost per fill; not the patient's out-of-pocket price.

88
30-Day Fills
standardized to 30-day supplies
2,640
Days of Medication
total across all patients in 2023

About Breztri Aerosphere: This product is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾

Controlling symptoms of breathing problems helps you maintain your normal activities and decreases time lost from work or school. This inhaler contains 3 medications: budesonide, glycopyrrolate, and formoterol. Budesonide works by reducing the irritation and swelling of the airways. Budesonide belongs to a class of drugs known as corticosteroids. Glycopyrrolate and formoterol work by relaxing the muscles around the airways so that they open up and you can breathe more easily. Glycopyrrolate belongs to a class of drugs known as anticholinergics. Formoterol belongs to the class of drugs known as long-acting beta agonists (LABAs). Both drugs are also known as bronchodilators. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden breathing problems. If sudden shortness of breath occurs, use your quick-relief inhaler as prescribed. This medication is not approved to treat asthma.

In 2023, this provider wrote 39 Medicare prescriptions for Breztri Aerosphere, about the same volume as the typical New York prescriber of this medication (41). Medicare paid an average of $873.02 per fill, versus $799.94 statewide.

How often this provider prescribes it

This provider
39
NY average
41.0

This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$873.02
NY average
$799.94

Gross Part D cost per fill; not the patient's out-of-pocket price.

55
30-Day Fills
standardized to 30-day supplies
1,650
Days of Medication
total across all patients in 2023

About Ventolin Hfa: Albuterol (also known as salbutamol) is used to treat wheezing and shortness of breath caused by breathing problems such as asthma. Show more ▾

It is a quick-relief medication. Albuterol belongs to a class of drugs known as bronchodilators. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.

In 2023, this provider wrote 38 Medicare prescriptions for Ventolin Hfa, about 1.5 times the volume of the typical New York prescriber of this medication (25). Medicare paid an average of $98.69 per fill, versus $75.39 statewide.

How often this provider prescribes it

This provider
38
NY average
25.0

This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$98.69
NY average
$75.39

Gross Part D cost per fill; not the patient's out-of-pocket price.

49
30-Day Fills
standardized to 30-day supplies
1,186
Days of Medication
total across all patients in 2023

About Modafinil: Modafinil reduces extreme sleepiness due to narcolepsy and other sleep disorders, such as periods of stopped breathing during sleep (obstructive sleep apnea). Show more ▾

It is also used to help you stay awake during work hours if you have a work schedule that keeps you from having a normal sleep routine (shift work sleep disorder). This medication does not cure these sleep disorders and may not get rid of all your sleepiness. Modafinil does not take the place of getting enough sleep. It should not be used to treat tiredness or hold off sleep in people who do not have a sleep disorder. It is not known how modafinil works to keep you awake. It is thought to work by affecting certain substances in the brain that control the sleep/wake cycle. A benzhydryl acetamide compound, central nervous system stimulant, and CYP3A4 inducing agent that is used in the treatment of NARCOLEPSY and SLEEP WAKE DISORDERS.

In 2023, this provider wrote 37 Medicare prescriptions for Modafinil, about 1.8 times the volume of the typical New York prescriber of this medication (21). Medicare paid an average of $43.51 per fill, versus $175.30 statewide.

How often this provider prescribes it

This provider
37
NY average
21.0

This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$43.51
NY average
$175.30

This provider's average cost per fill is below the NY average for this medication.

37
30-Day Fills
standardized to 30-day supplies
1,110
Days of Medication
total across all patients in 2023

About Advair Hfa: This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾

It contains 2 medications: fluticasone and salmeterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Salmeterol belongs to the class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. When used alone, long-acting beta agonists (such as salmeterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with one asthma-control medication (such as inhaled corticosteroid) or if your symptoms need combination treatment. Before using this medication, it is important to learn how to use it properly. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed.

In 2023, this provider wrote 33 Medicare prescriptions for Advair Hfa, about 1.6 times the volume of the typical New York prescriber of this medication (21). Medicare paid an average of $996.08 per fill, versus $616.39 statewide.

How often this provider prescribes it

This provider
33
NY average
21.0

This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$996.08
NY average
$616.39

Gross Part D cost per fill; not the patient's out-of-pocket price.

65
30-Day Fills
standardized to 30-day supplies
1,950
Days of Medication
total across all patients in 2023

About Zolpidem Tartrate Er: Zolpidem is used for a short time to treat a certain sleep problem (insomnia) in adults. Show more ▾

If you have trouble falling asleep, it helps you fall asleep faster, so you can get a better night's rest. Zolpidem belongs to a class of drugs called sedative-hypnotics. It acts on your brain to produce a calming effect. An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA.

In 2023, this provider wrote 28 Medicare prescriptions for Zolpidem Tartrate Er, about 1.8 times the volume of the typical New York prescriber of this medication (16). Medicare paid an average of $19.81 per fill, versus $37.51 statewide.

How often this provider prescribes it

This provider
28
NY average
16.0

This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$19.81
NY average
$37.51

This provider's average cost per fill is below the NY average for this medication.

28
30-Day Fills
standardized to 30-day supplies
840
Days of Medication
total across all patients in 2023

About Levalbuterol Tartrate Hfa: Levalbuterol is used to prevent and treat wheezing and shortness of breath caused by breathing problems (such as asthma, chronic obstructive pulmonary disease). Show more ▾

It is a quick-relief drug. Levalbuterol belongs to a class of drugs known as bronchodilators. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. This drug is not approved for use in children younger than 4 years due to increased risk of side effects (such as unusual fast breathing, worsening asthma). Ask your doctor or pharmacist for details.

In 2023, this provider wrote 22 Medicare prescriptions for Levalbuterol Tartrate Hfa, about the same volume as the typical New York prescriber of this medication (20). Medicare paid an average of $108.66 per fill, versus $75.79 statewide.

How often this provider prescribes it

This provider
22
NY average
20.0

This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$108.66
NY average
$75.79

Gross Part D cost per fill; not the patient's out-of-pocket price.

30.3
30-Day Fills
standardized to 30-day supplies
795
Days of Medication
total across all patients in 2023

About Trazodone Hcl: This medication is used to treat depression. Show more ▾

It may help to improve your mood, appetite, and energy level as well as decrease anxiety and insomnia related to depression. Trazodone works by helping to restore the balance of a certain natural chemical (serotonin) in the brain.

In 2023, this provider wrote 22 Medicare prescriptions for Trazodone Hcl, about a third of the volume of the typical New York prescriber of this medication (54). Medicare paid an average of $2.76 per fill, versus $10.71 statewide.

How often this provider prescribes it

This provider
22
NY average
54.0

This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$2.76
NY average
$10.71

This provider's average cost per fill is below the NY average for this medication.

32
30-Day Fills
standardized to 30-day supplies
960
Days of Medication
total across all patients in 2023

About Ofev: This medication is used to treat certain types of lung disease (idiopathic pulmonary fibrosis- IPF, interstitial lung disease). Show more ▾

Both types of lung disease scar and stiffen your lungs, making it hard to breathe. Nintedanib may help slow down the worsening of your lung disease.

In 2023, this provider wrote 20 Medicare prescriptions for Ofev, about 65% of the volume of the typical New York prescriber of this medication (31). Medicare paid an average of $13,423.40 per fill, versus $12,552.66 statewide.

How often this provider prescribes it

This provider
20
NY average
31.0

This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$13,423.40
NY average
$12,552.66

Gross Part D cost per fill; not the patient's out-of-pocket price.

20
30-Day Fills
standardized to 30-day supplies
600
Days of Medication
total across all patients in 2023

About Combivent Respimat: This product is used to treat and prevent symptoms (wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes bronchitis and emphysema). Show more ▾

This product contains 2 medications: ipratropium and albuterol (also known as salbutamol). Both drugs work by relaxing the muscles around the airways so that the airways open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school.

In 2023, this provider wrote 17 Medicare prescriptions for Combivent Respimat, about 74% of the volume of the typical New York prescriber of this medication (23). Medicare paid an average of $821.36 per fill, versus $591.76 statewide.

How often this provider prescribes it

This provider
17
NY average
23.0

This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$821.36
NY average
$591.76

Gross Part D cost per fill; not the patient's out-of-pocket price.

28
30-Day Fills
standardized to 30-day supplies
840
Days of Medication
total across all patients in 2023

About Bevespi Aerosphere: This product is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾

Controlling symptoms of breathing problems helps you maintain your normal activities and decreases time lost from work or school. This inhaler contains 2 medications: glycopyrrolate and formoterol. Both drugs work by relaxing the muscles around the airways so that they open up and you can breathe more easily. Glycopyrrolate belongs to a class of drugs known as anticholinergics. Formoterol belongs to the class of drugs known as long-acting beta agonists (LABAs). Both drugs are also known as bronchodilators. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden breathing problems. If sudden shortness of breath occurs, use your quick-relief inhaler as prescribed. Glycopyrrolate/formoterol is not approved to treat asthma. People with asthma using long-acting inhaled beta agonists (such as formoterol) without also using an inhaled corticosteroid may have an increased risk of serious (sometimes fatal) breathing problems.

In 2023, this provider wrote 17 Medicare prescriptions for Bevespi Aerosphere, about 89% of the volume of the typical New York prescriber of this medication (19). Medicare paid an average of $739.14 per fill, versus $570.49 statewide.

How often this provider prescribes it

This provider
17
NY average
19.0

This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$739.14
NY average
$570.49

Gross Part D cost per fill; not the patient's out-of-pocket price.

29
30-Day Fills
standardized to 30-day supplies
870
Days of Medication
total across all patients in 2023

About Dextroamphetamine-Amphetamine: This combination medication is used to treat attention deficit hyperactivity disorder - ADHD. Show more ▾

It works by changing the amounts of certain natural substances in the brain. Amphetamine/dextroamphetamine belongs to a class of drugs known as stimulants. It can help increase your ability to pay attention, stay focused on an activity, and control behavior problems. It may also help you to organize your tasks and improve listening skills. This drug is also used to treat a certain sleeping disorder (narcolepsy) to help you stay awake during the day. It should not be used to treat tiredness or to hold off sleep in people who do not have a sleep disorder.

In 2023, this provider wrote 16 Medicare prescriptions for Dextroamphetamine-Amphetamine, about half the volume of the typical New York prescriber of this medication (28). Medicare paid an average of $33.98 per fill, versus $39.64 statewide.

How often this provider prescribes it

This provider
16
NY average
28.0

This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$33.98
NY average
$39.64

This provider's average cost per fill is below the NY average for this medication.

16
30-Day Fills
standardized to 30-day supplies
476
Days of Medication
total across all patients in 2023

About Clonazepam: Clonazepam is used to prevent and control seizures. Show more ▾

This medication is known as an anticonvulsant or antiepileptic drug. It is also used to treat panic attacks. Clonazepam works by calming your brain and nerves. It belongs to a class of drugs called benzodiazepines. An anticonvulsant used for several types of seizures, including myotonic or atonic seizures, photosensitive epilepsy, and absence seizures, although tolerance may develop. It is seldom effective in generalized tonic-clonic or partial seizures. The mechanism of action appears to involve the enhancement of GAMMA-AMINOBUTYRIC ACID receptor responses.

In 2023, this provider wrote 16 Medicare prescriptions for Clonazepam, about a third of the volume of the typical New York prescriber of this medication (51). Medicare paid an average of $9.25 per fill, versus $10.30 statewide.

How often this provider prescribes it

This provider
16
NY average
51.0

This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$9.25
NY average
$10.30

This provider's average cost per fill is below the NY average for this medication.

16
30-Day Fills
standardized to 30-day supplies
480
Days of Medication
total across all patients in 2023

About Dupixent Syringe: This medication is used to treat certain skin conditions (eczema, prurigo nodularis) and a certain esophagus problem (eosinophilic esophagitis). Show more ▾

It is also used along with other medications to help control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma. In addition, dupilumab may be used to reduce symptoms caused by nasal polyps and the long-term swelling of the sinuses and nasal passage (chronic rhinosinusitis with nasal polyposis). Dupilumab belongs to a class of drugs known as monoclonal antibodies. It works by blocking certain natural proteins in your body (interleukin-4 and interleukin-13) that may cause inflammation and swelling. This medication should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed.

In 2023, this provider wrote 15 Medicare prescriptions for Dupixent Syringe, about 63% of the volume of the typical New York prescriber of this medication (24). Medicare paid an average of $3,239.89 per fill, versus $3,819.02 statewide.

How often this provider prescribes it

This provider
15
NY average
24.0

This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$3,239.89
NY average
$3,819.02

This provider's average cost per fill is below the NY average for this medication.

15
30-Day Fills
standardized to 30-day supplies
406
Days of Medication
total across all patients in 2023

About Nystatin: Nystatin is used to treat fungal skin infections. Show more ▾

Nystatin is an antifungal that works by stopping the growth of fungus. Macrolide antifungal antibiotic complex produced by Streptomyces noursei, S. aureus, and other Streptomyces species. The biologically active components of the complex are nystatin A1, A2, and A3.

In 2023, this provider wrote 13 Medicare prescriptions for Nystatin, about half the volume of the typical New York prescriber of this medication (25). Medicare paid an average of $14.89 per fill, versus $25.86 statewide.

How often this provider prescribes it

This provider
13
NY average
25.0

This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$14.89
NY average
$25.86

This provider's average cost per fill is below the NY average for this medication.

13
30-Day Fills
standardized to 30-day supplies
157
Days of Medication
total across all patients in 2023

About Armodafinil: Armodafinil reduces extreme sleepiness due to narcolepsy and other sleep disorders, such as periods of stopped breathing during sleep (obstructive sleep apnea). Show more ▾

It is also used to help you stay awake during work hours if you have a work schedule that keeps you from having a normal sleep routine (shift work sleep disorder). This medication does not cure these sleep disorders and may not get rid of all your sleepiness. Armodafinil does not take the place of getting enough sleep. It should not be used to treat tiredness or hold off sleep in people who do not have a sleep disorder. It is not known how armodafinil works to keep you awake. It is thought to work by affecting certain substances in the brain that control the sleep/wake cycle. A benzhydryl acetamide compound, central nervous system stimulant, and CYP3A4 inducing agent that is used in the treatment of NARCOLEPSY and SLEEP WAKE DISORDERS.

In 2023, this provider wrote 12 Medicare prescriptions for Armodafinil, about 67% of the volume of the typical New York prescriber of this medication (18). Medicare paid an average of $52.49 per fill, versus $77.60 statewide.

How often this provider prescribes it

This provider
12
NY average
18.0

This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$52.49
NY average
$77.60

This provider's average cost per fill is below the NY average for this medication.

12
30-Day Fills
standardized to 30-day supplies
360
Days of Medication
total across all patients in 2023

About Omeprazole: Omeprazole is used to treat certain stomach and esophagus problems (such as acid reflux, ulcers). Show more ▾

It works by decreasing the amount of acid your stomach makes. It relieves symptoms such as heartburn, difficulty swallowing, and cough. This medication helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Omeprazole belongs to a class of drugs known as proton pump inhibitors (PPIs). If you are self-treating with this medication, over-the-counter omeprazole products are used to treat frequent heartburn (occurring 2 or more days a week). Since it may take 1 to 4 days to have full effect, these products do not relieve heartburn right away. For over-the-counter products, carefully read the package instructions to make sure the product is right for you. Check the ingredients on the label even if you have used the product before. The manufacturer may have changed the ingredients. Also, products with similar brand names may contain different ingredients meant for different purposes. Taking the wrong product could harm you. A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.

In 2023, this provider wrote 11 Medicare prescriptions for Omeprazole, about 11% of the volume of the typical New York prescriber of this medication (96). Medicare paid an average of $4.27 per fill, versus $12.73 statewide.

How often this provider prescribes it

This provider
11
NY average
96.0

This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$4.27
NY average
$12.73

This provider's average cost per fill is below the NY average for this medication.

25
30-Day Fills
standardized to 30-day supplies
750
Days of Medication
total across all patients in 2023

About Diazepam: This medication is used to treat episodes of increased seizures (such as cluster or breakthrough seizures) in people who are already taking medications to control their seizures. Show more ▾

This product is only recommended for short-term treatment of seizure attacks. It is not for ongoing daily use to prevent seizures. Uncontrolled seizures can turn into serious (possibly fatal) seizures that do not stop (status epilepticus). This medication is not recommended for children younger than 6 months of age because of the risk of serious side effects. Diazepam works by calming the brain and nerves. It belongs to a class of drugs known as benzodiazepines. A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity.

In 2023, this provider wrote 11 Medicare prescriptions for Diazepam, about half the volume of the typical New York prescriber of this medication (26). Medicare paid an average of $0.90 per fill, versus $9.77 statewide.

How often this provider prescribes it

This provider
11
NY average
26.0

This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$0.90
NY average
$9.77

This provider's average cost per fill is below the NY average for this medication.

11
30-Day Fills
standardized to 30-day supplies
330
Days of Medication
total across all patients in 2023

About Zolpidem Tartrate: Zolpidem is used for a short time to treat a certain sleep problem (insomnia) in adults. Show more ▾

If you have trouble falling asleep, it helps you fall asleep faster, so you can get a better night's rest. Zolpidem belongs to a class of drugs called sedative-hypnotics. It acts on your brain to produce a calming effect. An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA.

In 2023, this provider wrote 11 Medicare prescriptions for Zolpidem Tartrate, about a quarter of the volume of the typical New York prescriber of this medication (52). Medicare paid an average of $12.08 per fill, versus $7.53 statewide.

How often this provider prescribes it

This provider
11
NY average
52.0

This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$12.08
NY average
$7.53

Gross Part D cost per fill; not the patient's out-of-pocket price.

11
30-Day Fills
standardized to 30-day supplies
330
Days of Medication
total across all patients in 2023

About Paxlovid (Eua): The combination of nirmatrelvir tablets and ritonavir tablets is a product that the FDA is allowing to be given for emergency use to treat COVID-19. Show more ▾

The product is also approved to be used in Canada to treat COVID-19. It is used by people who have recently tested positive for coronavirus, have had mild to moderate symptoms for no more than 5 days and are not hospitalized. To receive this product you must also be at high risk for COVID-19 complications due to older age, obesity, or ongoing medical conditions (such as lung or heart disease or diabetes, among others). Talk to your doctor about the risks and benefits of treatment with nirmatrelvir and ritonavir. Nirmatrelvir is a SARS-CoV-2 main protease inhibitor. It works by preventing the growth of the virus that causes COVID-19. Ritonavir increases (boosts) the levels of nirmatrelvir. This helps nirmatrelvir work better. More information about nirmatrelvir and ritonavir is available from the FDA Fact Sheet for Patients, Parents, and Caregivers for Emergency Use and from the Health Canada Patient Medication Information sheet. There is limited information about how safe and effective the combination of nirmatrelvir and ritonavir is for treating COVID-19. Study results show that nirmatrelvir and ritonavir may help people who have recently tested positive for coronavirus stay out of the hospital. This product is not for use by people who are hospitalized due to COVID-19. The information in this document reflects emerging data, which is evolving and subject to reassessment. Users should be aware of these considerations in their review of nirmatrelvir and ritonavir, and it is always the responsibility of treating practitioners to exercise independent judgement in making care decisions.

In 2023, this provider wrote 11 Medicare prescriptions for Paxlovid (Eua), about half the volume of the typical New York prescriber of this medication (24). Medicare paid an average of $9.89 per fill, versus $10.63 statewide.

How often this provider prescribes it

This provider
11
NY average
24.0

This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$9.89
NY average
$10.63

This provider's average cost per fill is below the NY average for this medication.

11
30-Day Fills
standardized to 30-day supplies
55
Days of Medication
total across all patients in 2023
No medications match the current filters.
= the 5 medications this provider prescribes most. More than typical Typical Less than typical= prescription volume vs the average NY prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the NY average cost per fill.

About this data. The prescription history for DR. HUNG DINH NGUYEN MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Internal Medicine prescribing approach at this Saratoga Springs, NY practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among NY prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.